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Abstract
In the classic paradigm of mammalian cell cycle control, Rb functions to restrict cells from 
entering S phase by sequestering E2F activators (E2f1, E2f2 and E2f3), which are invariably 
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portrayed as the ultimate effectors of a transcriptional program that commit cells to enter and 
progress through S phase1, 2. Using a panel of tissue-specific cre-transgenic mice and conditional 
E2f alleles we examine the effects of E2f1, E2f2 and E2f3 triple deficiency in murine ES cells, 
embryos and small intestines. We show that in normal dividing progenitor cells E2F1-3 function 
as transcriptional activators, but contrary to current dogma, are dispensable for cell division and 
instead are necessary for cell survival. In differentiating cells they function in complex with Rb as 
repressors to silence E2F targets and facilitate exit from the cell cycle. The inactivation of Rb in 
differentiating cells resulted in a switch of E2F1-3 from repressors to activators, leading to the 
superactivation of E2F responsive targets and ectopic cell divisions, and loss of E2f1-3 completely 
suppressed these phenotypes. This work contextualizes the activator versus repressor functions of 
E2F1-3 in vivo, revealing distinct roles in dividing versus differentiating cells and in normal 
versus cancer-like cell cycles in vivo.
Keywords
Small intestine; cell cycle; E2F; retinoblastoma; tumor suppressor
E2Fs function as transcription factors, with E2F1-3 as activators and E2F4-8 as repressors3–
8. Although it is a maxim of mammalian cell cycle regulation that the E2F1-3 activator 
subclass is required for cell proliferation, the evidence for this is based almost exclusively 
on in vitro studies using cells derived from murine and human tissues or on the in vivo 
analysis of Rb mutant mice1, 2. Other experiments, however, suggest that these E2Fs can 
also function as repressors in complex with Rb9–11, yet the relative contribution of 
activation version repression and the physiological contexts in which these contrary E2F 
functions are employed remain unclear.
To explore the functions of the E2F activator subclass, we derived 
E2f1−/−;E2f2−/−;E2f3LoxP/− ES cells (Supplementary Fig. 1a, 1b) and compared the 
consequences of inactivating the conditional E2f3LoxP allele in these cells versus in 
E2f1−/−;E2f2−/−;E2f3LoxP/LoxP MEFs. The expression of E2f1, E2f2 and E2f3 in wild type 
ES cells was generally higher than in MEFs and the loading of E2F3 protein on classic E2F 
target promoters was comparable between the two proliferating cell types (Supplementary 
Fig. 2a-c). Consistent with previous observations, the ablation of E2f1-3 in MEFs with 
standard cre-expressing vectors led to the induction of p53 activity, the loading of E2F4-
p130 repressor complexes on E2F target promoters and a marked decrease in E2F target 
expression (Fig. 1a, Supplementary Fig. 3a–c)5–7. Consequently, triply deficient MEFs 
underwent a complete cell cycle arrest (Fig. 1b)5–7. In contrast, 
E2f1−/−;E2f2−/−;E2f3Δ/−(TKO) ES cells failed to activate p53 or form E2F4/p130 repressive 
complexes, and as a result, E2F target expression was unaffected and cells proliferated 
equally well as E2f1−/−;E2f2−/−;E2f3LoxP/− (DKO) control cells (Supplementary Fig. 3a-c).
We then evaluated whether triply-deficient ES cells could proliferate in vivo. Subcutaneous 
injection of TKO ES cells into athymic nude mice yielded efficient teratoma formation, 
producing mesoderm, endoderm, and ectoderm at a rate similar to DKO ES lines (Fig. 1c, 
Supplementary Fig. 4a, 4b). Moreover, from E2f1+/−;E2f2−/−;E2f3+/− intercrosses we 
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recovered the expected number of live TKO embryos as late as E9.5, but none were 
recovered past E11.5 (Fig. 1d, and data not shown). The live E9.5 TKO embryos appeared 
morphologically normal by gross and histological examination (Fig. 1e and data not shown). 
While cell proliferation was normal in most tissues, there was evidence of decreased 
proliferation and increased apoptosis in the myocardium and the first branchial arch of TKO 
embryos (Supplementary Fig. 5a–d). These latter observations are consistent with heart 
defects found in E2f3 singly-deleted adult mice12.
To explore whether E2F1-3 might have cell cycle-related functions in tissues that arise later 
in embryonic and postnatal development, we exploited the highly organized cellular 
architecture of the small intestine. Maintenance of structural and functional integrity of the 
small intestine requires continuous epithelial regeneration13. Intestinal stem cells are housed 
at the base of crypts of Lieberkühn and give rise to transit-amplifying cells. As these cells 
migrate up from the base and into the finger-like extensions called villi, they exit the cell 
cycle and differentiate13. Western blot assays showed that E2f1, E2f2 and both isoforms of 
E2f3 (E2F3a and E2F3b) are expressed in the crypt and villus (Supplementary Fig. 6). We 
used Ah-cre mice14 to ablate E2f1-3 in the small intestine in utero or in adult mice (Ah-
cre;E2f1−/−;E2f2−/−;E2f3LoxP/LoxP, TKO). Induction of Ah-cre expression by intraperitoneal 
injection of β-napthoflavone (β-NF) led to the efficient deletion of E2f3LoxP in crypt stem 
cells and transit-amplifying cells by one day post-injection, and in the entire intestinal 
epithelium within 3–4 days (crypt and villus; Supplementary Fig. 7a–c). Loss of E2f1-3 did 
not result in a compensatory increase of other E2F family members, except for a modest 
increase in E2f8 (Supplementary Fig. 7d). Whether E2f3LoxP was deleted in utero at E15.5 
or in the adult at 2 months of age, the architecture of TKO small intestines remained 
relatively intact and animals were asymptomatic for 90 days following β-NF administration 
(Fig. 2a, Supplementary Fig. 8a, 8b). Cell-type specific marker analysis demonstrated that 
all differentiated epithelial cell-types were appropriately represented in TKO small intestines 
(Fig. 2b, Supplementary Fig. 9). Remarkably, cell proliferation was identical in TKO and 
control intestines (Fig. 2c), however, we noted a marked increase in γ-H2AX and P-
ATM1981 staining in TKO crypts and villi (Fig. 2d, 2e, Supplementary Fig. 10a). A parallel 
analysis of retinal (Chen et al, accompanying manuscript) and lens (P.W. unpublished 
observations) progenitors also revealed increased γ-H2AX staining in TKO samples 
(Supplementary Fig. 10b, 10c). Together, these observations suggest that counter to current 
dogma, E2F1-3 are dispensable for the proliferation of embryonic stem cells and their 
mesodermal, endodermal, and ectodermal derivatives, and cells in at least some adult 
tissues.
Close examination of H&E-stained slides revealed increased numbers of pyknotic nuclei in 
TKO crypts (data not shown). TUNEL and cleaved caspase-3 assays confirmed the presence 
of apoptotic cells in crypts of TKO intestines (Fig. 2f). We also observed increased p53 
immunoreactivity in TKO crypts (Supplementary Fig. 11a), which was reminiscent of 
previous work showing exquisite sensitivity of this cellular compartment to oncogene- and 
radiation-induced p53 responses15. While p53 was elevated in TKO crypts, we failed to 
detect any significant increase in the expression of p53-responsive genes and moreover, the 
conditional ablation of p53 (Ah-cre;E2f1−/−;E2f2−/−;E2f3LoxP/LoxP;p53LoxP/LoxP) did not 
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suppress the apoptosis caused by E2f1-3 deficiency (Supplementary Fig. 11b, 11c). 
Together, these surprising observations suggest that E2F1-3 are dispensable for cell division 
in the adult and that at least in the small intestine, they function in a p53-independent 
manner to maintain DNA integrity and cell survival.
To understand the underlying mechanism for these unexpected results, we isolated crypt and 
villus cell populations from control and E2f1-3-deficient (TKO) small intestines and 
analyzed global gene expression profiles. Sample preparation and processing of the 
Affymetrix oligo-arrays are described in the Methods section. We utilized an unbiased 
method similar to Gene Set Enrichment Analysis to identify genes that were differentially 
expressed16. Two variables contributed to the observed gene expression changes, cell 
compartment (crypt vs. villus) and genotype (TKO vs. control). The cell compartment 
analysis compared gene expression in crypts and villi of the same genotype (Fig. 3a). For 
control small intestines, this revealed that among the ~45K genes queried, 1207 genes were 
upregulated and 2363 genes were downregulated as progenitor cells in the crypt migrated up 
into the villus and exited the cell cycle (>1.5-fold, p<0.0001; Supplementary Fig. 12a, 
Supplementary Table 1). As expected, the expression of most known E2F targets, as defined 
by previous gene expression17, reporter and chromatin immunoprecipitation assays18 
(Supplementary Fig. 12b), was markedly higher in control crypts than in associated villi 
(Fig. 3a, left panel), consistent with the proliferative status of crypts. For TKO small 
intestines, the expression of E2F targets in crypts was only marginally higher than in their 
associated villi (Fig. 3a, right panel), suggesting that expression of these genes were either 
reduced in crypts, elevated in villi, or both.
The genotype analysis compared gene expression in TKO vs. control samples of the same 
cell compartment. This comparison revealed a modest but significant downregulation of E2F 
targets in progenitor cells of TKO crypts, which included many but not all known classic 
targets such as Cdc6, Cyclin A2, Cyclin E2, Top2, and Hmgb2 (Fig. 3b–c, left panels, 
Supplementary Fig. 13a). We suspect that continued proliferation of TKO progenitors in the 
small intestine when E2F targets are limiting likely contributes to replicative stress, DNA 
damage and the observed increase in γ-H2AX labeling in these cells. Whether these aberrant 
processes are linked to the death of TKO progenitor cells remains to be rigorously evaluated. 
The genotype comparison also revealed a remarkable upregulation of a large number of E2F 
targets in differentiated cells of the TKO villus (Fig. 3b–c, right panels, Supplementary Fig. 
13a). Western blot assays and IF staining showed that the accumulation of two of these E2F 
target gene products, Mcm3 and Pcna, was widespread throughout the TKO villus (Fig. 3d, 
Supplementary Fig. 13b). Similarly, there was increased expression of E2F targets in 
differentiated TKO cells of the retina and lens (Supplementary Fig. 13c; PW unpublished 
observations), suggesting a general role for E2F1-3 in transcriptional repression in post-
mitotic cells in vivo. Chromatin immunoprecipitation (ChIP) assays using villus-enriched 
lysates derived from control and TKO small intestines showed that E2F3 occupies E2F 
binding sites on classic E2F-target promoters (Fig. 3e). Importantly, coimmunoprecipitation 
assays using intestinal epithelial cells derived from E2f3−/−, E2f3a−/− and E2f3b−/− villi 
showed that both E2F3a/b isoforms19–21 participate in a complex with the Rb protein (Fig. 
3f). Consistent with this, Rb was found to be hypophosphorylated in the villus 
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(Supplementary Fig. 14a). Together, these data suggest that E2F1-3 act as transcription 
activators in dividing progenitors, and as repressors (in complex with Rb) in differentiating 
cells of the small intestine.
On the surface, the observation that E2F1-3 repress E2F targets and are dispensable for cell 
proliferation contradict previous findings from the analysis of Rb/E2f double knockout 
animals1, 2, 8. Therefore, to thoroughly explore the mechanistic relationship between Rb 
and E2F1-3, we used the small intestine as an in vivo system where results could be 
uniformly compared across different genetic configurations. The Ah-cre mediated 
inactivation of Rb in utero or in adult mice resulted in increased proliferation of cells in the 
villus compartment but not in the crypt (Fig. 4a, 4b, Supplementary Fig. 14b–e), indicating 
that Rb-deleted transit-amplifying cells failed to appropriately exit the cell cycle. There was, 
however, no concomitant increase in apoptosis or defect in cell differentiation 
(Supplementary Fig. 15a, 15b), and as a result, Rb-deficient villi appeared uniformly 
hyperplastic. The combined ablation of the three E2fs completely suppressed the 
unscheduled proliferation and hyperplasia caused by Rb deficiency (QKO; Fig. 4a, 4b, 
Supplementary Fig. 16a). Importantly, the basal levels of proliferation in QKO crypts were 
indistinguishable from control or TKO samples (Supplementary Fig. 16b), consistent with 
the rather normal development of E2f1-3 deficient small intestines containing an intact Rb 
gene.
The selective requirement for E2f1-3 in the proliferation of Rb-deficient cells provided an 
opportunity to dissect possible cancer-specific mechanisms of E2F in cell cycle control. We 
therefore compared global gene expression programs in control, RbKO, TKO and QKO 
intestinal epithelia. Several important insights came from this analysis. First, there were 
expansive gene expression differences between control and RbKO villi (1290 upregulated 
and 487 downregulated genes; Fig. 4c, Supplementary Table 2), but relatively minor 
differences in their associated crypts (Supplementary Fig. 17a, 17b). Gene Ontology 
algorithms22 identified a bias for differentially expressed genes involved in the regulation of 
transcription, DNA metabolic processes and cell cycle (Supplementary Table 3). IF and 
quantitative RT-PCR assays confirmed the dramatic accumulation of most E2F-target genes 
in RbKO villi (Supplementary Fig. 17c–d). From these data we conclude that Rb is critical 
for the repression of E2F targets at a time when progenitor cells commit to exit the cell cycle 
and terminally differentiate. Second, hierarchical clustering of all data sets showed that TKO 
and QKO tissues clustered together in a separate group from control and RbKO tissues 
(Supplementary Fig. 18), suggesting that some functions coordinated by E2F1-3 may be Rb-
independent. Finally and most importantly, the expression levels of E2F targets in TKO and 
QKO villi were equivalent, and while higher than in control villi, they were substantially 
lower than in RbKO villi (Fig. 4c). Quantitative RT PCR assays confirmed the relative 
expression of E2F targets to be: control < TKO = QKO ≪ RbKO (Fig. 4d). From these data, 
we conclude that the supra-elevated expression of E2F targets observed in RbKO villi is due 
to both ‘derepression’ (lacking intact Rb/E2F1-3 repressor complexes) and E2F1-3 mediated 
‘hyper-activation’. In the absence of E2F1-3 mediated hyper-activation, cells in QKO villi 
fail to hyper-activate and thus do not accumulate sufficient levels of E2F targets to undergo 
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‘ectopic’ cell proliferation (this threshold level of expression is illustrated as a red dotted 
line in Fig. 4d).
We provide overwhelming evidence showing that normal cell proliferation in mice can be 
maintained in the absence of activator E2Fs. We conclude that E2F1-3, like G1 Cdk’s23–25, 
are not as critical for normal cell proliferation in mammals as original studies implied3, 4, 
26–29. However, not all is well in the absence of E2F1-3, since TKO dividing progenitors in 
the small intestine undergo apoptosis. A prosurvival role for E2F1-3 was also evident in 
retinal progenitor cells of the mouse (Chen et al., accompanying paper), however, in the 
retina cell death was p53 dependent whereas in the small intestine it was p53 independent. 
Thus, the sensitivity of cells to p53 activation varies considerably across tissue types.
The findings presented here also expose dual functions for E2F1-3 in transcription activation 
and repression in vivo. In dividing progenitor cells, when Rb is inactive 
(hyperphosphorylated), free E2F1-3 are employed to optimally activate the expression of 
target genes. The inability to do so in E2f1-3 deficient tissues still permits cells to replicate 
their DNA and divide, but at the cost of increased DNA damage and cell death. As cells 
commit to a terminally differentiated fate, P-Rb is dephosphorylated and forms a physical 
complex with E2F1-3 proteins. We propose that this is not to just sequester E2F activators 
but rather, to form the first repressive complex that is necessary to downregulate E2F targets 
and usher transit-amplifying cells out of the cell cycle. Once cells exit the cell cycle, other 
professional repressor complexes accumulate, including p130/E2F4 and p107/E2F4, to more 
permanently enforce the repression of E2F targets. Given that inactivation of Rb, but not 
p107 or p13030, induces ectopic cell divisions in the small intestine, we suggest that Rb has 
a unique role in transit-amplifying cells that is dependent on its ability to associate with 
E2F1-3. Maintenance of quiescence in terminally differentiated cells of the villus, however, 
is a function that is shared among all members of the Rb family30. In summary, this work 
challenges the current paradigm of cell cycle control and provides, for the first time, a 
unified molecular view of how the dual functions of E2F1-3 in transcriptional activation and 
repression are employed in vivo to control normal versus Rb-mutant or cancer cell cycles.
METHODS SUMMARY
Mice (E2f1−/−, E2f2−/−, E2f3f/f, Ah-cre and Rbf/f) used for the studies were in mixed 
background (129SvEv, C57BL/6NTac and FVB/NTac). β-napthoflavone (sigma; 
N3633-5G) was administered into 2 month old Ah-cre mice three times within 24 hours as 
described previously14 and mice were harvested 7 or 90 days later. β-napthoflavone was 
also injected into pregnant female mice at 15.5 days postcoitum for analysis of embryos at 
E18.5. Villus and crypt fractions were isolated as previously described8. Three independent 
samples from each genetic group were used for gene expression analysis by Affymetrix 
microarray. Analysis of gene expression data were performed using BRB-array tools 
developed by Dr. Richard Simon and Amy Peng Lam of the National Cancer Institute. Gene 
Ontologies were predicted by DAVID (Database for Annotation, Visualization and 
Integrated Discovery) Bioinformatics Resources at the National Institute of Allergy and 
Infectious diseases, NIH. X-gal staining, real-time RT-PCR, BrdU, ChIP and TUNEL assays 
were performed as previously described8, 19. Primers for ChIP, real-time RT-PCR and 
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genotyping are listed in Supplementary Fig. 19a-b. Antibodies used for Western blot or 
immunohistochemical staining are listed in Supplementary Fig. 19c.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Cell proliferation in the absence of E2f1-3
a Expression of E2F-regulated genes was measured by real-time RT-PCR in proliferating 
ES and MEFs cells with the indicated genotypes (primer information is provided in 
Supplementary Fig. 19). b. Growth curves of two sets of DKO and TKO ES cell clones (A 
and B) and DKO and TKO MEFs. c. DKO and TKO ES cells were injected underneath the 
skin of athymic nude mice and teratomas were harvested, sectioned and stained with H&E. 
Representative tissues of DKO and TKO teratomas include muscle (mesoderm), respiratory 
epithelium (endoderm), skin and neural cells (ectoderm). d. Embryos derived from 
intercrosses between E2f1+/−;E2f2−/−;E2f3+/− mice were collected at various timepoints 
during pregnancies. e. Representative E9.5 embryos were photographed immediately upon 
collection; E2f2−/− (SKO), E2f2−/−;E2f3−/− (DKO), and E2f1−/−E2f2−/−E2f3−/− (TKO) 
embryos.
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Figure 2. Apoptosis of crypt intestinal cells in the absence of E2f1, E2f2, and E2f3
a H&E stained sections from E2f1−/−;E2f2−/−;E2f3LoxP/LoxP (control) and Ah-
cre;E2f1−/−;E2f2−/−;E2f3LoxP/LoxP (Ah-cre) intestines after 90 days of β-NF administration. 
b. Analysis of cell differentiation in control and Ah-cre small intestines. Goblet cells were 
identified by Alcian blue staining (arrows point to positive-stained goblet cells); absorptive 
cells were identified by anti-Fatty acid binding protein (FABP, green) antibodies; DAPI 
(blue) was used for staining nuclei. c. BrdU (brown) and phosphorylated histone H3 (P-H3, 
red) immunohistochemical staining was performed on small intestine sections from β-NF 
injected control and Ah-cre mice. Quantification of BrdU- and phosphorylated histone H3-
positive cells in crypts and villi. n=3, 3 different animals with the indicated genotypes were 
analyzed (bottom panels); error bars indicate standard deviation. d. Immunohistochemical 
staining for γ-H2AX, P-ATM1981 in control and Ah-cre intestinal crypts and villi. The 
orange dotted line outlines the luminal side of the villus; the white dotted line outlines the 
outer side of the villus. DAPI (blue) was used for staining nuclei. e. Examination of γ-H2AX 
and P-ATM1981 in cell extracts from control and Ah-cre intestinal crypts and villi by 
Western blot assays. f. Sections of small intestines from β-NF injected control and Ah-cre 
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mice were processed for TUNEL (brown) and cleaved caspase-3 (red) assays. DAPI (blue) 
or hematoxylin was used for staining nuclei. Quantification of TUNEL and cleaved 
caspase-3 positive cells in crypts and villi (bottom panels). n=3, 3 different animals with the 
indicated genotypes were analyzed; error bars indicate standard deviation.
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Figure 3. Repression of E2F-target genes in E2f1-3 deficient villi
a Scatter plots comparing expression of known E2F-target genes (see Supplementary Fig. 
16b) between cell compartments (crypt and villus); E2f1−/−;E2f2−/−;E2f3LoxP/LoxP (control) 
and Ah-cre;E2f1−/−;E2f2−/−;E2f3LoxP/LoxP (Ah-cre). Genes with >1.5-fold increase in 
expression are depicted as red dots. b. Scatter plots comparing expression of known E2F-
target genes between genotypes (control and Ah-cre samples); n=3 for each of the four 
samples. Red dots indicate genes whose expression increased >1.5-fold and blue dots 
indicate genes that decreased >1.5-fold. c. Quantitative real-time PCR was performed to 
compare the relative expression of selected E2F-target genes in control and Ah-cre crypts 
(left panels) and villi (right panels) using specific primers (Supplementary Fig. 20). d. 
Immunohistochemical staining of Mcm3 (green) and Pcna (red) in control and Ah-cre villi. 
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DAPI (blue) was used for staining nuclei. Yellow dotted line outlines the luminal side of the 
villus; white dotted line outlines the outer side of the villus. Note that staining of blood cells 
in lumens of villi is non-specific. e. Chromatin immunoprecipitation (ChIP) assays using 
IgG or anti-E2F3 (α-3) antibodies with lysates from wild-type villi (Antibody control; top 
panels). ChIP assays using anti-E2F3 (α-3) antibodies with lysates from wild type (con) and 
Ah-cre (TKO) villi (Genotype control: bottom panels). Primers flanking known E2F-binding 
elements were used to detect the indicated gene promoters (Supplementary Fig. 19). f. Co-
immunoprecipitation assays of cell extracts prepared from control villi and crypts. 
Imunoprecipitations (IP) used anti-E2F3 antibody or IgG. Anti-Rb antibody was used to 
probe Western blot (WB; left panel). The specificity of the anti-E2F3 antibody used in the 
left panel was evaluated in intestinal lysates derived from Ah-cre (3−/−), E2f3a−/− (3a−/−), 
E2f3b−/− (3b−/−) and E2f3+/+ mice. Anti-Rb antibody was used to probe Western blot (WB; 
right panel).
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Figure 4. E2F1-3 contribute to the ectopic cell proliferation caused by Rb-deficiency
a BrdU analysis was performed in E2f1−/−;E2f2−/−;E2f3LoxP/LoxP (control), Ah-
cre;RbLoxP/LoxP (RbKO) and Ah-cre;E2f1−/−;E2f2−/−;E2f3LoxP/LoxP;RbLoxP/LoxP (QKO) 
small intestines. b. Quantification of BrdU incorporation. n=3, 3 different animals with the 
indicated genotypes were analyzed; error bars indicate standard deviation. c. Scatter plot 
analysis comparing differentially expressed E2F target genes in control, RbKO, Ah-
cre;E2f1−/−;E2f2−/−;E2f3LoxP/LoxP (TKO) and QKO villi; n=3 for each of the eight samples. 
Red dots indicate genes whose expression increased >1.5-fold and blue dots indicate gene 
that decreased >1.5-fold. d. Quantitative RT-PCR analysis of selected E2F-target genes in 
control (con), RbKO, TKO, and QKO villi. The normal basal level of E2F target expression 
is illustrated as a grey dotted line and the threshold level of E2F target expression required 
for ectopic proliferation is illustrated as a red dotted line.
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